Evaluating the impact of beauty care on cancer patients' well-being
Evaluation of the Medical Service by Socio-aesthetics in Oncology
This study is testing whether professional beauty care or self-care products can help cancer patients feel better and manage pain and anxiety during chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier de Valence Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Nice and 2 other locations) |
| Trial ID | NCT06035731 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial investigates the effects of socio-aesthetics well-being care on the quality of life, pain, and anxiety in patients undergoing chemotherapy for various cancers. Participants will be randomly assigned to receive either professional socio-aesthetic care or self-administer dermo-cosmetics during their treatment. The study aims to assess the impact of these interventions through multiple evaluations over a three-year period. Data will be collected using electronic case report forms to ensure accurate tracking of patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old currently receiving chemotherapy for lung, breast, colon, or prostate cancer.
Not a fit: Patients who are unable to participate due to medical, social, or psychological reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and emotional well-being of cancer patients during treatment.
How similar studies have performed: While there is limited data from randomized controlled trials on socio-aesthetics care, this approach is relatively novel in the context of oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * over 18 years old * treated with chemotherapy for lung , breast, colon or prostate cancer * Able to understand, read, and write French, * Affiliated with a social security scheme, * Having dated and signed an informed consent. Exclusion Criteria: * Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study, * Deprived of their liberty by court or administrative decision,
Where this trial is running
Nice and 2 other locations
- Centre Antoine Lacassagne — Nice, France (Recruiting)
- Ap Hp — Paris, France (Recruiting)
- Chru Tours — Tours, France (Recruiting)
Study contacts
- Principal investigator: Guillaume Guillaume — Ch Valence
- Study coordinator: Guillaume Guillaume, PHD
- Email: gbuiret@ch-valence.fr
- Phone: +33475752555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.